NCT03000257 2022-04-14
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
AbbVie
Phase 1 Completed
Clinical Trials
6 trialsNCT03086239 2021-08-03
A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer
AbbVie
Phase 1 Completed
NCT02674568 2021-07-30
TRINITY
AbbVie
Phase 2 Completed
NCT03061812 2021-02-23
TAHOE
AbbVie
Phase 3 Completed
NCT02874664 2018-09-24
A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer
Stemcentrx
Phase 1 Completed
NCT01901653 2018-08-09
Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer
Stemcentrx
Phase 1/2 Completed